Multitarget fluorescence in situ hybridization and melanoma antigen genes analysis in primary bladder carcinoma

Cancer Genetics and Cytogenetics

Volumn 164, Issue 1, 2006, Pages 32-38

  Kang, Ji Un ^a   Koo, Sun Hoe ^a   Jeong, Tae Eun ^a   Kwon, Kye Chul ^a   Park, Jong Woo ^a   Jeon, Chang Ho ^b  

^a Chungnam National University College of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN;

ADULT; AGED; ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9P; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC PROCEDURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; URINALYSIS; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 29244471041     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.06.006     Document Type: Article

References (34)

1. L. Bubendorf, B. Grilli, G. Sauter, M.J. Mihatsch, T.C. Gasser, and P. Dalquen Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings Am J Clin Pathol 116 2001 79 86
2. S. Ramakumar, J. Bhuiyan, J.A. Besse, S.G. Roberts, P.C. Wollan, M.L. Blute, and D.J. O'Kane Comparison of screening methods in the detection of bladder cancer J Urol 161 1999 388 394
3. M.F. Sarosdy, M.A. Hudson, W.J. Ellis, M.S. Soloway, R. de Vere White, J. Sheinfeld, M.V. Jarowenko, P.F. Schellhammer, E.W. Schervish, J.V. Patel, G.W. Chodak, D.L. Lamm, R.D. Johnson, M. Henderson, G. Adams, B.A. Blumenstein, K.R. Thoelke, R.D. Pfalzgraf, H.A. Murchison, and S.L. Brunelle Improved detection of recurrent bladder cancer using the Bard BTA stat Test Urology 50 1997 349 353
4. M.S. Soloway, V. Briggman, G.A. Carpinito, G.W. Chodak, P.A. Church, D.L. Lamm, P. Lange, E. Messing, R.M. Pasciak, G.B. Reservitz, D.B. Rukstalis, M.F. Sarosdy, W.M. Stadler, R.P. Thiel, and C.L. Hayden Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment J Urol 156 1996 363 367
5. B.S. Schmetter, K.K. Habicht, D.L. Lamm, A. Morales, N.H. Bander, H.B. Grossman, M.G. Hanna Jr., S.R. Silberman, and B.T. Butman A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer J Urol 158 1997 801 805
6. A.S. Glas, D. Roos, M. Deutekom, A.H. Zwinderman, P.M. Bossuyt, and K.H. Kurth Tumor markers in the diagnosis of primary bladder cancer: A systematic review J Urol 169 2003 1975 1982
7. Y. Fradet, and C. Lockhard Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark Can J Urol 4 1997 400 405
8. P. Van der Bruggen, C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1991 1643 1647
9. A.M. Meloni, A.M. Peier, F.S. Haddad, I.J. Powell, A.W. Block, R.P. Huben, I. Todd, W. Potter, and A.A. Sandberg A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors Cancer Genet Cytogenet 71 1993 105 118
10. R. Veeramachaneni, M.L. Nordberg, R. Shi, G.A. Herrera, and E.A. Turbat-Herrera Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma Diagn Cytopathol 28 6 2003 301 307
11. M.F. Sarosdy, P. Schellhammer, G. Bokinsky, P. Kahn, R. Chao, L. Yore, J. Zadra, D. Burzon, G. Osher, J.A. Bridge, S. Anderson, S.L. Johansson, M. Lieber, M. Soloway, and K. Flom Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer J Urol 168 2002 1950 1954
12. J.Y. Ro, G.A. Staerkel, and A.G. Ayala Cytologic and histologic features of superficial bladder cancer Urol Clin North Am 19 1992 435 453
13. K.C. Halling, W. King, I.A. Sokolova, R.G. Meyer, H.M. Burkhardt, A.C. Halling, J.C. Cheville, T.J. Sebo, S. Ramakumar, C.S. Stewart, S. Pankratz, D.J. O'Kane, S.A. Seelig, M.M. Lieber, and R.B. Jenkins A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma J Urol 164 2000 1768 1775
14. K.C. Halling, W. King, I.A. Sokolova, R.J. Karnes, R.G. Meyer, E.L. Powell, T.J. Sebo, J.C. Cheville, A.C. Clayton, K.L. Krajnik, T.A. Ebert, R.E. Nelson, H.M. Burkhardt, S. Ramakumar, C.S. Stewart, V.S. Pankratz, M.M. Lieber, M.L. Blute, H. Zincke, S.A. Seelig, R.B. Jenkins, and D.J. O'Kane A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine J Urol 167 2002 2001 2006
15. E. De Plaen, K. Arden, C. Traversari, J.J. Gaforio, J.P. Szikora, C. De Smet, F. Brasseur, P. van der Bruggen, B. Lethe, C. Lurquin, R. Brasseur, P. Chomez, O. De Backer, W. Cavenee, and T. Boon Structure, chromosomal localization, and expression of 12 genes of the MAGE family Immunogenetics 40 1994 360 369
16. M.S. Park, J.W. Park, C.H. Jeon, K.D. Lee, and H.K. Chang Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans J Korean Med Sci 17 2002 497 501
17. I.D. Fleming, J.S. Cooper, D.E. Henson, R.V.P. Hutter, B.J. Kennedy, G.P. Murphy, B. O'Sullivan, L.H. Sobin, and J.W. Yarbro AJCC cancer staging manual 5th edition 1997 Lippincott-Raven Publishers Philadelphia
18. L.G. Koss Tumors of the urinary bladder 1975 Armed Forces Institute of Pathology Washington DC
19. I.A. Sokolova, K.C. Halling, R.B. Jenkins, H.M. Burkhardt, R.G. Meyer, S.A. Seelig, and W. King The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine J Mol Diagn 2 2000 116 123
20. A.H. Hopman, F.C. Ramaekers, A.K. Raap, J.L. Beck, P. Devilee, M. van der Ploeg, and G.P. Vooijs In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors Histochemistry 89 1988 307 316
21. M. Skacel, M. Fahmy, J.A. Brainard, J.D. Pettay, C.V. Biscotti, L.S. Liou, G.W. Procop, J.S. Jones, J. Ulchaker, C.D. Zippe, and R.R. Tubbs Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology J Urol 169 2003 2101 2105
22. J. Placer, B. Espinet, M. Salido, F. Sole, and A. Gelabert-Mas Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology Eur Urol 42 2002 547 552
23. U.S. Food and Drug Administration. 2001 and 2002 statistics at a glance. Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID= 4159 and http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID= 6483. Accessed August 3, 2001 and February 8, 2002
24. J.W. Park, T.K. Kwon, I.H. Kim, S.S. Sohn, Y.S. Kim, C.I. Kim, O.S. Bae, K.S. Lee, K.D. Lee, C.S. Lee, H.K. Chang, B.K. Choe, S.Y. Ahn, and C.H. Jeon A new strategy for the diagnosis of MAGE-expressing cancers J Immunol Methods 266 2002 79 86
25. F.M. Brown Urine cytology. It is still the gold standard for screening? Urol Clin North Am 27 2000 25 37
26. A. Pycha, C. Mian, A. Haitel, J. Hofbauer, H. Wiener, and M. Marberger Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer J Urol 157 1997 2116 2119
27. F.F. Zhang, D.A. Arber, T.G. Wilson, M.H. Kawachi, and M.L. Slovak Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations Clin Cancer Res 3 1997 2317 2328
28. A. Marano, Y. Pan, C. Li, A. Pagliarulo, G. Elmberger, B. Tribukait, P. Ekman, and U. Bergerheim Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer Eur Urol 37 2000 358 365
29. A. Pycha, C. Mian, A. Haitel, J. Hofbauer, H. Wiener, and M. Marberger Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer J Urol 157 1997 2116 2119
30. F.F. Zhang, D.A. Arber, T.G. Wilson, M.H. Kawachi, and M.L. Slovak Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations Clin Cancer Res 3 1997 2317 2328
31. J. Zhao, J. Richter, U. Wagner, B. Roth, P. Schraml, T. Zellweger, D. Ackermann, U. Schmid, H. Moch, M.J. Mihatsch, T.C. Gasser, and G. Sauter Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa) Cancer Res 59 1999 4658 4661
32. J. Richter, F. Jiang, J.P. Gorog, G. Sartorius, C. Egenter, T.C. Gasser, H. Moch, M.J. Mihatsch, and G. Sauter Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization Cancer Res 57 1997 2860 2864
33. C.H. Spruck 3rd, P.F. Ohneseit, M. Gonzalez-Zulueta, D. Esrig, N. Miyao, Y.C. Tsai, S.P. Lerner, C. Schmutte, A.S. Yang, R. Cote, L. Dubeau, P.W. Nichols, G.G. Hermann, K. Steven, T. Horn, D.G. Skinner, and P.A. Jones Two molecular pathways to transitional cell carcinoma of the bladder Cancer Res 54 1994 784 788
34. A. Zambon, S. Mandruzzato, A. Parenti, B. Macino, P. Dalerba, A. Ruol, S. Merigliano, G. Zaninotto, and P. Zanovello MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia Cancer 91 2001 1882 1888